Search Results - "Bhattacharyya, Dibyangana D."

The Role of Nitric Oxide in Cancer: Master Regulator or NOt? by Khan, Faizan H, Dervan, Eoin, Bhattacharyya, Dibyangana D, McAuliffe, Jake D, Miranda, Katrina M, Glynn, Sharon A

“…Nitric oxide (NO) is a key player in both the development and suppression of tumourigenesis depending on the source and concentration of NO. In this review, we…”
Get full text

Ancient Adversary – HERV-K (HML-2) in Cancer by Dervan, Eoin, Bhattacharyya, Dibyangana D., McAuliffe, Jake D., Khan, Faizan H., Glynn, Sharon A.

“…Human endogenous retroviruses (HERV), ancient integrations of exogenous viruses, make up 8% of our genome. Long thought of as mere vestigial genetic elements,…”
Get full text

Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment by McGinity, Christopher L, Palmieri, Erika M, Somasundaram, Veena, Bhattacharyya, Dibyangana D, Ridnour, Lisa A, Cheng, Robert Y S, Ryan, Aideen E, Glynn, Sharon A, Thomas, Douglas D, Miranda, Katrina M, Anderson, Stephen K, Lockett, Stephen J, McVicar, Daniel W, Wink, David A

“…The metabolic requirements and functions of cancer and normal tissues are vastly different. Due to the rapid growth of cancer cells in the tumor…”
Get full text

Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density by Somasundaram, Veena, Ridnour, Lisa A., Cheng, Robert YS, Walke, Abigail J., Kedei, Noemi, Bhattacharyya, Dibyangana D., Wink, Adelaide L., Edmondson, Elijah F., Butcher, Donna, Warner, Andrew C., Dorsey, Tiffany H., Scheiblin, David A., Heinz, William, Bryant, Richard J., Kinders, Robert J., Lipkowitz, Stanley, Wong, Stephen TC, Pore, Milind, Hewitt, Stephen M., McVicar, Daniel W., Anderson, Stephen K., Chang, Jenny, Glynn, Sharon A., Ambs, Stefan, Lockett, Stephen J., Wink, David A.

“…Antitumor immune polarization is a key predictor of clinical outcomes to cancer therapy. An emerging concept influencing clinical outcome involves the spatial…”
Get full text

Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors by Ridnour, Lisa A, Cheng, Robert Ys, Kedei, Noemi, Somasundaram, Veena, Bhattacharyya, Dibyangana D, Basudhar, Debashree, Wink, Adelaide L, Walke, Abigail J, Kim, Caleb, Heinz, William F, Edmondson, Elijah F, Butcher, Donna O, Warner, Andrew C, Dorsey, Tiffany H, Pore, Milind, Kinders, Robert J, Lipkowitz, Stanley, Bryant, Richard J, Rittscher, Jens, Wong, Stephen Tc, Hewitt, Stephen M, Chang, Jenny C, Shalaby, Aliaa, Callagy, Grace M, Glynn, Sharon A, Ambs, Stefan, Anderson, Stephen K, McVicar, Daniel W, Lockett, Stephen J, Wink, David A

“…Immune therapy is the new frontier of cancer treatment. Therapeutic radiation is a known inducer of immune response and can be limited by immunosuppressive…”
Get full text